These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6709691)

  • 21. Pharmacokinetics of digoxin in patients with acute myocardial infarction.
    Korhonen UR; Jounela AJ; Pakarinen AJ; Pentikäinen PJ; Takkunen JT
    Am J Cardiol; 1979 Nov; 44(6):1190-4. PubMed ID: 495514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations.
    Bjornsson TD; Huang AT; Roth P; Jacob DS; Christenson R
    Clin Pharmacol Ther; 1986 Jan; 39(1):25-8. PubMed ID: 3943266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intersubject variation in absorption of digoxin in normal volunteers.
    Huffman DH; Manion CV; Azarnoff DL
    J Pharm Sci; 1975 Mar; 64(3):433-7. PubMed ID: 1151628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
    O'Grady J; Johnson BF; Bye C; French J
    Eur J Clin Pharmacol; 1978 Dec; 14(5):357-60. PubMed ID: 729628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability of digoxin in capsules.
    Padeletti L; Brat A
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):320-2. PubMed ID: 669878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of metoclopramide on digoxin absorption from tablets and capsules.
    Johnson BF; Bustrack JA; Urbach DR; Hull JH; Marwaha R
    Clin Pharmacol Ther; 1984 Dec; 36(6):724-30. PubMed ID: 6499354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability of digoxin capsules and tablets: effect of coadministered fluid volume.
    Bustrack JA; Katz JD; Hull JH; Foster JR; Hammond JE; Christenson RH
    J Pharm Sci; 1984 Oct; 73(10):1397-400. PubMed ID: 6502488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the biologic availability of digoxin in man.
    Fleckenstein L; Kroening B; Weintraub M
    Clin Pharmacol Ther; 1974 Sep; 16(3):435-43. PubMed ID: 4606249
    [No Abstract]   [Full Text] [Related]  

  • 29. Bioavailability and related heart function index of digoxin capsules and tablets in cardiac patients.
    Astorri E; Bianchi G; La Canna G; Assanelli D; Visioli O; Marzo A
    J Pharm Sci; 1979 Jan; 68(1):104-6. PubMed ID: 364006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration.
    Johnson BF; Bye C
    Br Heart J; 1975 Feb; 37(2):203-8. PubMed ID: 1091283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum-digoxin concentrations with a new digoxin derivative, beta-methyl-digoxin.
    Härtel G; Manninen V; Melin J; Apajalahti A
    Ann Clin Res; 1973 Apr; 5(2):87-90. PubMed ID: 4748756
    [No Abstract]   [Full Text] [Related]  

  • 32. Superior bioavailability of digoxin solution in capsules.
    Mallis GI; Schmidt DH; Lindenbaum J
    Clin Pharmacol Ther; 1975 Dec; 18(6):761-8. PubMed ID: 1106935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digoxin and congestive heart failure.
    Fantini F; Lucchini CR; Padeletti L; Marsilii A; Dolara P; Mannelli M
    Acta Cardiol; 1977; 32(5):353-62. PubMed ID: 304654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Enhanced bioavailability of digoxin from silica matrix formulations (author's transl)].
    Flasch H; Asmussen B; Heinz N
    Arzneimittelforschung; 1978; 28(2):326-30. PubMed ID: 205226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability of digoxin and beta-methyl-digoxin.
    Padeletti L; Fantini F; Cinelli P; Gremigni C
    J Int Med Res; 1976; 4(5):352-4. PubMed ID: 1028636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biological availability of digoxin and beta-acetyldigoxin after single-dose administration (author's transl)].
    Clasen R; Kemmeter H; Gilfrich HJ
    Dtsch Med Wochenschr; 1979 Apr; 104(15):543-6. PubMed ID: 436626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biological availability of diagoxin in patients with or without gastric resection (Billroth II) (author's transl)].
    Ochs H; Bodem G; Kodrat G; Savic B; Baur MP
    Dtsch Med Wochenschr; 1975 Nov; 100(47):2430-4. PubMed ID: 810339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers.
    Bansinath M; Ghosh SS; Shafiqa A; Shukla VK; Chopra KS; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):30-3. PubMed ID: 3957487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study of the absolute bioavailability of four oral digoxin preparations (author's transl)].
    Rietbrock N; Alken RG; Ebert W
    Arzneimittelforschung; 1979; 29(11):1742-5. PubMed ID: 583489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioavailability studies with Digoxin-Sandoz and Lanoxin.
    Beveridge T; Kalberer F; Nüesch E; Schmidt R
    Eur J Clin Pharmacol; 1975 Jun; 8(5):371-6. PubMed ID: 1243983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.